Intrathecal Drug Delivery for Pain and Spasticity
Volume 2: A Volume in the Interventional and Neuromodulatory Techniques for Pain Management Series; Expert Consult Enhanced Online Features and Print
By- Asokumar Buvanendran, Associate Professor, Department of Anesthesiology Rush University Medical Center Chicago, IL
- Sudhir Diwan, Director of Pain Medicine, Department of Anesthesiology, Director of Quad-Institutional Pain Medicine Fellowship Program, Weill Cornell Medical College
- Timothy Deer, MD, President and CEO, The Center for Pain Relief Clinical Professor of Anesthesiology, West Virginia University School of Medicine Charleston, West Virginia
Intrathecal Drug Delivery for Pain and Spasticity - a volume in the new Interventional and Neuromodulatory Techniques for Pain Management series - presents state-of-the-art guidance on the full range of intrathecal drug delivery techniques performed today. Asokumar Buvanendran, MD and Sudhir Diwan, MD, offer expert advice on a variety of procedures to treat chronic non-malignant pain, cancer pain, and spasticity. Comprehensive, evidence-based coverage on selecting and performing these techniques - as well as weighing relative risks and complications - helps you ensure optimum outcomes. With access to the fully searchable text at www.expertconsult.com, youll have the detailed visual assistance you need right at your fingertips.
Audience
Anesthesiology
Hardbound, 224 Pages
Published: September 2011
Imprint: Saunders
ISBN: 978-1-4377-2217-8
Contents
SECTION I: General Considerations
Chapter 1: Basic Science of Spinal Receptors
Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs
Chapter 3: Polyanalgesia for Implantable Drug Delivery SystemsChapter 4: Principles of Patient Management for Intrathecal Analgesia
Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain
Chapter 6: Patient Preparation
Chapter 7: Psychological Considerations in IDD
Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and BillingSECTION II: Implant Devices
Chapter 9: Methods of Trials for Consideration of ITDDSChapter 10: Techniques of Implant Placement for Intrathecal PumpsChapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery
Chapter 12: SynchroMed EL vs SynchroMed II
Chapter 13: Minimizing the Risks of Intrathecal TherapyChapter 14: Complications Associated with Intrathecal Drug Delivery Systems
SECTION III: Evidence-based practice
Chapter 15: Management of ITDDS in Patients with Co-MorbiditiesChapter 16: Cost-Effectiveness of Implanted Drug Delivery SystemsChapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems
Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems
Chapter 19: Intrathecal Therapy for Malignant Pain
SECTION IV: ITDDs for spasticity
Chapter 20: Intrathecal Baclofen TrialingChapter 21: Baclofen Pump ManagementSECTION V: Future of ITDDs
Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)
Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy
Chapter 24: Perioperative Management of Patients with ITDDS
